Hong Kong tycoon Li Ka-shing to subsidise liver cancer surgery for 200 patients

Hong Kong tycoon Li Ka-shing’s charity will expand support for liver cancer patients by subsidising surgery fees for 200 patients over the next three years, enabling access to cutting-edge treatment at a cost of HK$50,000 (US$6,380).Announcing the initiative on Wednesday, the Li Ka Shing Foundation said eligible patients would be selected by three partnering private hospitals to undergo histotripsy surgery, which typically costs about HK$260,000 for Hong Kong identity card holders.Histotripsy is a non-invasive treatment that uses high-intensity ultrasound waves to precisely disrupt and liquefy targeted tumour cells without harming surrounding healthy tissue. Each session lasts about 15 to 25 minutes and is performed under general anaesthesia.